A new consensus report on the management of type 1 diabetes in adults was presented recently at the European Association for the Study of Diabetes (EASD) meetings. This is an EASD/American Diabetes ...

This week, the FDA approved a new treatment called teplizumab that delays the onset of type 1 diabetes. TZIELD, the brand name, will total $193,000 over the 14-day treatment. Experts say the new ...

Fulminant type 1 diabetes is a recently discovered subtype of type 1 diabetes. It is defined as diabetes in which the process of β-cell destruction and the progression of hyperglycemia and ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. In 2024 Stephen Rich and his colleagues ...

Children who were recently diagnosed with type 1 diabetes need less supplemental insulin to keep their blood sugar in a healthy range if they use the immunotherapy drug teplizumab, a new study reports ...